New treatment may cure hormonal high blood pressure
New treatment may cure hormonal high blood pressure
New treatment may cure hormonal high blood pressure
Key points
اہم نکات
मुख्य बातें
- A study led by Queen Mary University of London has found that a short course of a new class of drugs could offer a lasting cure for some people with a common hormonal cause of high blood pressure, Medical Xpress reports.
- The treatment, called extended aldosterone synthase inhibition (EASI), targets excess production of the hormone aldosterone, which causes primary aldosteronism, behind 5 to 10 percent of high blood pressure cases.
- In the study, published in the New England Journal of Medicine, 14 people at eight centres in the United States took the drugs for 6 to 12 months.
- A study led by Queen Mary University of London has found that a short course of a new class of drugs could offer a lasting cure for some people with a common hormonal cause of high blood pressure, Medical Xpress reports.
- The treatment, called extended aldosterone synthase inhibition (EASI), targets excess production of the hormone aldosterone, which causes primary aldosteronism, behind 5 to 10 percent of high blood pressure cases.
- In the study, published in the New England Journal of Medicine, 14 people at eight centres in the United States took the drugs for 6 to 12 months.
- A study led by Queen Mary University of London has found that a short course of a new class of drugs could offer a lasting cure for some people with a common hormonal cause of high blood pressure, Medical Xpress reports.
- The treatment, called extended aldosterone synthase inhibition (EASI), targets excess production of the hormone aldosterone, which causes primary aldosteronism, behind 5 to 10 percent of high blood pressure cases.
- In the study, published in the New England Journal of Medicine, 14 people at eight centres in the United States took the drugs for 6 to 12 months.
A study led by Queen Mary University of London has found that a short course of a new class of drugs could offer a lasting cure for some people with a common hormonal cause of high blood pressure, Medical Xpress reports. The treatment, called extended aldosterone synthase inhibition (EASI), targets excess production of the hormone aldosterone, which causes primary aldosteronism, behind 5 to 10 percent of high blood pressure cases. In the study, published in the New England Journal of Medicine, 14 people at eight centres in the United States took the drugs for 6 to 12 months. Their excess aldosterone production stayed reversed and their blood pressure partly or fully resolved for up to two years after treatment ended. Until now, a cure has required surgery to remove an entire adrenal gland. Researchers are now running a larger trial, called ELIXIR, to confirm the result.
A study led by Queen Mary University of London has found that a short course of a new class of drugs could offer a lasting cure for some people with a common hormonal cause of high blood pressure, Medical Xpress reports. The treatment, called extended aldosterone synthase inhibition (EASI), targets excess production of the hormone aldosterone, which causes primary aldosteronism, behind 5 to 10 percent of high blood pressure cases. In the study, published in the New England Journal of Medicine, 14 people at eight centres in the United States took the drugs for 6 to 12 months. Their excess aldosterone production stayed reversed and their blood pressure partly or fully resolved for up to two years after treatment ended. Until now, a cure has required surgery to remove an entire adrenal gland. Researchers are now running a larger trial, called ELIXIR, to confirm the result.
A study led by Queen Mary University of London has found that a short course of a new class of drugs could offer a lasting cure for some people with a common hormonal cause of high blood pressure, Medical Xpress reports. The treatment, called extended aldosterone synthase inhibition (EASI), targets excess production of the hormone aldosterone, which causes primary aldosteronism, behind 5 to 10 percent of high blood pressure cases. In the study, published in the New England Journal of Medicine, 14 people at eight centres in the United States took the drugs for 6 to 12 months. Their excess aldosterone production stayed reversed and their blood pressure partly or fully resolved for up to two years after treatment ended. Until now, a cure has required surgery to remove an entire adrenal gland. Researchers are now running a larger trial, called ELIXIR, to confirm the result.
Most read
سب سے زیادہ پڑھی گئی
सबसे ज़्यादा पढ़ी गई
- Loading...
Get news in your inbox
خبریں اپنے ان باکس میں حاصل کریں
खबरें अपने इनबॉक्स में पाएं
One email when new stories are published. No spam, unsubscribe anytime.
نئی خبریں شائع ہونے پر ایک ای میل۔ کوئی سپیم نہیں، کسی بھی وقت ان سبسکرائب کریں۔
नई खबरें प्रकाशित होने पर एक ईमेल। कोई स्पैम नहीं, कभी भी अनसब्सक्राइब करें।